Eli Lilly and Co Options Trading: A Deep Dive into Market Sentiment

Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly and Co.

Looking at options history for Eli Lilly and Co LLY we detected 22 trades.

If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and 59% with bearish.

From the overall spotted trades, 6 are puts, for a total amount of $181,850 and 16, calls, for a total amount of $3,057,626.

Projected Price Targets

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $490.0 to $830.0 for Eli Lilly and Co during the past quarter.

Volume & Open Interest Development

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Eli Lilly and Co's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly and Co's whale trades within a strike price range from $490.0 to $830.0 in the last 30 days.

Eli Lilly and Co Call and Put Volume: 30-Day Overview

Options Call Chart

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
LLY CALL SWEEP NEUTRAL 04/05/24 $188.4 $181.9 $185.65 $580.00 $1.8M 100 0
LLY CALL SWEEP BEARISH 06/21/24 $48.4 $45.6 $45.65 $770.00 $457.8K 1.0K 100
LLY CALL TRADE BEARISH 05/17/24 $17.35 $16.85 $17.04 $830.00 $166.9K 778 403
LLY CALL SWEEP BULLISH 05/17/24 $15.1 $13.5 $14.37 $830.00 $143.5K 778 101
LLY CALL SWEEP NEUTRAL 09/20/24 $60.05 $57.35 $58.69 $800.00 $64.5K 645 11

About Eli Lilly and Co

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Having examined the options trading patterns of Eli Lilly and Co, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance

Where Is Eli Lilly and Co Standing Right Now?

  • With a volume of 393,887, the price of LLY is down -0.55% at $763.86.
  • RSI indicators hint that the underlying stock may be approaching overbought.
  • Next earnings are expected to be released in 25 days.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Eli Lilly and Co with Benzinga Pro for real-time alerts.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date of Trade
▲▼
ticker
▲▼
Put/Call
▲▼
Strike Price
▲▼
DTE
▲▼
Sentiment
▲▼
Posted In: OptionsMarketsBZI-UOA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!